Suresh Chand Singla's Insider Trades & SAST Disclosures
Suresh Chand Singla's most recent trade in Titan Biotech Ltd. was a Acquisition of 1,702 Equity Shares done at an average price of Rs. 68.5 . Disclosure was reported to the exchange on June 17, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Suresh Chand Singla in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Titan Biotech | Suresh Chand Singla | Promoter | Acquisition | 17 Jun 2020 | 1,702 | 105,671 (1.27%) | 0.02% | 68.5 | 116,587 | 16 Jun 2020 16 Jun 2020 |
Insider Trading | Equity Shares | None |
| Titan Biotech | Suresh Chand Singla | Promoter | Acquisition | 16 Jun 2020 | 2,000 | 103,969 (1.25%) | 0.02% | 70 | 140,000 | 15 Jun 2020 15 Jun 2020 |
Insider Trading | Equity Shares | None |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.